Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoid X Receptor Alpha (RXRα) is a nuclear receptor and transcription factor that mediates the biological effects of retinoids. It plays a crucial role in regulating genes involved in various metabolic processes, including fatty acid oxidation, glucose and lipid metabolism, cholesterol metabolism, and bile acid homeostasis. RXRα also participates in immune responses and hepatic fibrosis. Activated primarily by 9-cis retinoic acid (9cRA), it forms homodimers or heterodimers with other nuclear receptors such as RARs, PPARs, LXRs and VDRs to regulate gene transcription.
RXRα binds as a homodimer or heterodimer to specific DNA sequences (response elements) in the promoters of target genes. Upon ligand (e.g., 9cRA) binding, RXRα recruits coactivators, leading to transcriptional activation. In the absence of ligand, it associates with corepressors, leading to transcriptional repression.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoid X Receptor Alpha (RXRα).